Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
Operating margin (%) -570.28
IBB's Operating margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: -570.28 )
IBB' s 10-Year Operating margin (%) Range
Min: 0   Max: 0
Current: -570.28

» Details

Guru Trades

Q4 2013

IBB Guru Trades in Q4 2013

Louis Moore Bacon 85,996 sh (New)
» More
Q1 2014

IBB Guru Trades in Q1 2014

Louis Moore Bacon 14,000 sh (-83.72%)
» More
Q3 2014

IBB Guru Trades in Q3 2014

George Soros 150,000 sh (unchged)
» More
Q4 2014

IBB Guru Trades in Q4 2014

John Keeley 905 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with IBB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
EV-to-EBIT 10.60
IBB's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 10.60 )
IBB' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: 10.6

PEG 1.30
IBB's PEG is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 1.30 )
IBB' s 10-Year PEG Range
Min: 0   Max: 1.3
Current: 1.3

0
1.3

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.40
IBB's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 0.40 )
IBB' s 10-Year Dividend Yield Range
Min: 0   Max: 0
Current: 0.4

Yield on cost (5-Year) 0.40
IBB's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 0.40 )
IBB' s 10-Year Yield on cost (5-Year) Range
Min: 0   Max: 0
Current: 0.4

Valuation & Return

vs
industry
vs
history

Business Description

Industry: »
Compare:KH, CTFO, GBG, URGP, GPRM » details
» More Articles for IBB

Headlines

Articles On GuruFocus.com
No related article found.

More From Our Partners
Pharma ETFs Soar on Acquisition Spree - ETF News And Commentary Apr 13 2015 - ZACKS

More From Other Websites
Biogen shares are tanking because a 71% surge in profits just wasn't enough Apr 24 2015
This horrific one-day chart sums up why biotech investing requires nerves of steel Apr 24 2015
Amgen raises full-year guidance Apr 21 2015
Market continues to give reason for higher prices Apr 21 2015
It has been a historic year for biotech mergers and it might not be over yet Apr 21 2015
Stocks mixed amid earnings; Nasdaq leads gains Apr 21 2015
Biotech ETF Run not Over Yet, Says Analyst Apr 21 2015
Why This Trader Likes Gilead Better Than Biogen Apr 19 2015
Are The Bulls & Bears About To Resolve Their Standoff? Apr 18 2015
Promising cancer drugs Apr 17 2015
Adam Feuerstein Says If You Believe In A Biotech Bubble, It Hasn't Burst Apr 17 2015
Reasons to bet on new Breed Biotech ETFs Apr 17 2015
TheStreet's Adam Feuerstein And Other Industry Experts Join #PreMarket Prep For In-Depth Analysis of... Apr 15 2015
Curing eye disease, and maybe color blindness Apr 14 2015
Big money settles in for an extended bull run Apr 14 2015
5 biotech bets: Trading a surging sector Apr 09 2015
5 biotech bets: Large & small Apr 09 2015
Conditions are ripe for the intermediate-term speculator Apr 09 2015
Top trades to go before the closing bell Apr 08 2015
Bio Tech- Support test in play after large reversal pattern Apr 07 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK